TT virus infection in patients with chronic hepatitis B and response of TTV to lamivudine

doi:10.3748/wjg.v9.i6.1261

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2038)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

202

HTML

1705

Tables (1-4)

131

Sum=2038

Jun 15, 2003 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jun 15, 2003; 9(6): 1261-1264
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1261

Table 1 Comparison of serum TTV DNA concentration changes before treatment and at the end of treatment

	Non-responders (n = 7)	Responders (n = 8)	P^a
Before treatment	4.6 × 10⁷	8.0 × 10⁷	0.66
End of treatment	1.1 × 10⁸	3.4 × 10⁷	0.29

TTV DNA concentration was expressed as viral genomes/mL of serum. ^aStudent's t-test, HBV non-responsive patients vs. responsive patients to lamivudine therapy.

Citation: Garcia JM, Marugan RB, Garcia GM, Lindeman MLM, Abete JF, Terron SDC. TT virus infection in patients with chronic hepatitis B and response of TTV to lamivudine. World J Gastroenterol 2003; 9(6): 1261-1264
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1261.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1261